UC BON.CAP.CERT. 12/24 NESR/ DE000HD93BC3 /
2024-11-08 9:46:31 PM | Chg.-3.020 | Bid9:59:58 PM | Ask9:59:58 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
105.300EUR | -2.79% | 106.110 Bid Size: 500 |
107.070 Ask Size: 500 |
Nestle S.A. | - - | 2024-12-31 | Call |
GlobeNewswire
08-13
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
08-06
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
GlobeNewswire
07-23
Mondelēz International Names Filippo Catalano Chief Information and Digital Officer
GlobeNewswire
06-12
NFWF Announces $10.2 Million in Grants to Cultivate Conservation Practices on Agricultural Lands
GlobeNewswire
06-06
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
05-08
WalkMe Announces Date of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
03-26
NESTLE INTERNATIONAL AWARDED OMNIQ A PURCHASE ORDER FOR THE SUPPLY OF RUGGEDIZED IOT EQUIPMENT TO NE...
GlobeNewswire
03-19
VML Augments Digital Commerce Capabilities by Forging Partnership with CommerceIQ’s Unified Artifici...